ENTITY
China Resources Sanjiu Medical & Pharma

China Resources Sanjiu Medical & Pharma (000999 CH)

52
Analysis
Health CareChina
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. manufactures and markets medicines, healthcare products, and medical instruments. Through its subsidiaries, the Company also operates in pharmaceutical trading, printing, food manufacturing, real estate development, and provides medical services.
more
08 Aug 2024 08:55

CR Sanjiu (000999.CH) To Acquire Tasly Pharma (600535.CH) - SOEs Have High Enthusiasm for TCM Assets

​China Resources Sanjiu to acquire 28% stake in Tasly for RMB6.21 billion, aligning with strategic goals of 14th Five-Year Plan. Market is...

Logo
318 Views
Share
25 Mar 2024 08:55

China Resources Sanjiu (000999.CH) - 2023 Results Below Expectations; Short-Term Headwinds Remain

Sanjiu’s 2023 results was below expectations. Growth in 2024 would be lower than that in 2023. Whether the performance would turnaround depends on...

Logo
291 Views
Share
26 Nov 2023 10:04

China Healthcare Weekly (Nov.24) - Gold Content Of License-Out Deals, NRDL Pricing Levels, CR Sanjiu

Only a direct/non-refundable upfront payment represent the true value of licensing deal.NRDL price of innovative drug becomes stable, with three...

Logo
384 Views
Share
17 Mar 2024 19:50

China Healthcare Weekly (Mar.15)- New Policy of Innovative Drug, TCM Formula Granules, Xingqi Pharma

New policy of innovative drug is a big deal. We've reasons to start being optimistic.The market pattern of TCM formula granules will face...

Logo
342 Views
Share
bearishHKEX
19 Nov 2023 05:30

Index Rebalance & ETF Flow Recap: FRTIB, Japan, CSI300, CSI500, STAR50, WuXi XDC, Asahi

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
650 Views
Share
x